CCL22 and cancer: Our findings have translational relevance by suggesting future clinical investigation of the TRAIL innate immune pathway, CCL22, and TLR7 in toxicity of radiation or other cancer therapeutics and in other inflammatory lung or skin conditions, and have implications for radiation countermeasures.